$9
5.22%
Downside
Day's Volatility :12.51%
Upside
7.69%
25.67%
Downside
52 Weeks Volatility :84.44%
Upside
79.07%
Period | Engene Holdings Inc | Index (Russel 2000) |
---|---|---|
3 Months | -41.94% | 0.0% |
6 Months | 16.73% | 0.0% |
1 Year | -55.0% | 0.0% |
3 Years | -55.0% | -20.2% |
Market Capitalization | 397.5M |
Book Value | $5.5 |
Earnings Per Share (EPS) | -2.61 |
Wall Street Target Price | 32.5 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -29.38% |
Return On Equity TTM | -330.6% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -44.5M |
Diluted Eps TTM | -2.61 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -1.49 |
EPS Estimate Next Year | -1.58 |
EPS Estimate Current Quarter | -0.26 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 261.11%
Sell
Neutral
Buy
Engene Holdings Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Engene Holdings Inc | 12.5% | 16.73% | -55.0% | -55.0% | -55.0% |
Moderna, Inc. | -1.67% | 18.26% | -0.21% | -64.15% | 752.69% |
Regeneron Pharmaceuticals, Inc. | -0.46% | 13.21% | 45.59% | 84.19% | 244.2% |
Novo Nordisk A/s | -11.0% | 18.31% | 61.56% | 186.46% | 423.59% |
Vertex Pharmaceuticals Incorporated | 3.85% | 14.43% | 39.88% | 147.45% | 195.07% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Engene Holdings Inc | NA | NA | NA | -1.49 | -3.31 | -0.29 | NA | 5.5 |
Moderna, Inc. | 24.73 | NA | 0.0 | -7.19 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 31.35 | 31.35 | 1.46 | 44.44 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 44.28 | 44.28 | 2.36 | 3.43 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 31.85 | 31.85 | 0.53 | 16.98 | 0.24 | 0.13 | NA | 71.8 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Engene Holdings Inc | Buy | $397.5M | -55.0% | NA | 0.0% |
Moderna, Inc. | Buy | $45.3B | 752.69% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $116.9B | 244.2% | 31.35 | 29.45% |
Novo Nordisk A/s | Buy | $572.0B | 423.59% | 44.28 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $126.7B | 195.07% | 31.85 | 39.46% |
Organization | Engene Holdings Inc |
Employees | 31 |
CEO | Mr. Jason D. Hanson Esq., J.D. |
Industry | Miscellaneous |
A Spac I Acquisition Corp
$9.00
+0.0%
Keyarch Acquisition Corp
$9.00
+0.0%
Connexa Sports Technologies Inc
$9.00
+0.0%
Us Value Etf
$9.00
+0.0%
First Wave Biopharma Inc
$9.00
+0.0%
Global X Msci Next Emerging
$9.00
+0.0%
Fat Projects Acquisition Corp
$9.00
+0.0%
Capital Link Global Fintech
$9.00
+0.0%
Applied Uv Inc
$9.00
+0.0%